Abstract
Influenza A viruses (IAVs) cause substantial morbidity and mortality in yearly epidemics, which result from the ability of the virus to alter the antigenicity of its envelope proteins. Despite the rapid replication of this virus and its ability to infect a wide variety of cell types, viremia is rare and the infection is generally limited to the upper respiratory tract. The preimmune host defense response against IAV is generally, therefore, successful. We have previously provided (and summarized) evidence that neutrophils contribute to defense against IAV, although neutrophil dysfunction and local tissue damage may be less salutory byproducts of this response. Here we provide evidence that the serum lectin mannose-binding protein directly inhibits hemagglutinin activity and infectivity of several strains of IAV. In addition mannose-binding protein acts as an opsonin, enhancing neutrophil reactivity against IAV. Opsonization of IAV by mannose-binding protein also protects the neutrophil from IAV-induced dysfunction. These effects are observed with physiologically relevant concentrations of mannose-binding protein. Two different allelic forms of recombinant mannose-binding protein are found to have similar effects. We believe, on the basis of these data, that mannose-binding protein alone and in conjunction with phagocytic cells is an important constituent of natural immunity (i.e., preimmune defense) against IAV.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anders E. M., Hartley C. A., Jackson D. C. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4485–4489. doi: 10.1073/pnas.87.12.4485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cassidy L. F., Lyles D. S., Abramson J. S. Depression of polymorphonuclear leukocyte functions by purified influenza virus hemagglutinin and sialic acid-binding lectins. J Immunol. 1989 Jun 15;142(12):4401–4406. [PubMed] [Google Scholar]
- Caton A. J., Brownlee G. G., Yewdell J. W., Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell. 1982 Dec;31(2 Pt 1):417–427. doi: 10.1016/0092-8674(82)90135-0. [DOI] [PubMed] [Google Scholar]
- Couch R. B., Kasel J. A. Immunity to influenza in man. Annu Rev Microbiol. 1983;37:529–549. doi: 10.1146/annurev.mi.37.100183.002525. [DOI] [PubMed] [Google Scholar]
- Ezekowitz R. A. Ante-antibody immunity. Curr Biol. 1991 Feb;1(1):60–62. doi: 10.1016/0960-9822(91)90132-g. [DOI] [PubMed] [Google Scholar]
- Ezekowitz R. A., Day L. E., Herman G. A. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J Exp Med. 1988 Mar 1;167(3):1034–1046. doi: 10.1084/jem.167.3.1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ezekowitz R. A., Kuhlman M., Groopman J. E., Byrn R. A. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med. 1989 Jan 1;169(1):185–196. doi: 10.1084/jem.169.1.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hartley C. A., Jackson D. C., Anders E. M. Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin. J Virol. 1992 Jul;66(7):4358–4363. doi: 10.1128/jvi.66.7.4358-4363.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hartshorn K. L., Collamer M., Auerbach M., Myers J. B., Pavlotsky N., Tauber A. I. Effects of influenza A virus on human neutrophil calcium metabolism. J Immunol. 1988 Aug 15;141(4):1295–1301. [PubMed] [Google Scholar]
- Hartshorn K. L., Collamer M., White M. R., Schwartz J. H., Tauber A. I. Characterization of influenza A virus activation of the human neutrophil. Blood. 1990 Jan 1;75(1):218–226. [PubMed] [Google Scholar]
- Hartshorn K. L., Daigneault D. E., White M. R., Tauber A. I. Anomalous features of human neutrophil activation by influenza A virus are shared by related viruses and sialic acid-binding lectins. J Leukoc Biol. 1992 Mar;51(3):230–236. doi: 10.1002/jlb.51.3.230. [DOI] [PubMed] [Google Scholar]
- Hartshorn K. L., Daigneault D. E., White M. R., Tuvin M., Tauber J. L., Tauber A. I. Comparison of influenza A virus and formyl-methionyl-leucyl-phenylalanine activation of the human neutrophil. Blood. 1992 Feb 15;79(4):1049–1057. [PubMed] [Google Scholar]
- Hartshorn K. L., Karnad A. B., Tauber A. I. Influenza A virus and the neutrophil: a model of natural immunity. J Leukoc Biol. 1990 Feb;47(2):176–186. doi: 10.1002/jlb.47.2.176. [DOI] [PubMed] [Google Scholar]
- Hartshorn K. L., Tauber A. I. The influenza virus--infected phagocyte. A model of deactivation. Hematol Oncol Clin North Am. 1988 Jun;2(2):301–315. [PubMed] [Google Scholar]
- Kuhlman M., Joiner K., Ezekowitz R. A. The human mannose-binding protein functions as an opsonin. J Exp Med. 1989 May 1;169(5):1733–1745. doi: 10.1084/jem.169.5.1733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malhotra R., Thiel S., Reid K. B., Sim R. B. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med. 1990 Sep 1;172(3):955–959. doi: 10.1084/jem.172.3.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakamura K., Compans R. W. Host cell- and virus strain-dependent differences in oligosaccharides of hemagglutinin glycoproteins of influenza A viruses. Virology. 1979 May;95(1):8–23. doi: 10.1016/0042-6822(79)90397-0. [DOI] [PubMed] [Google Scholar]
- Ratcliffe D. R., Nolin S. L., Cramer E. B. Neutrophil interaction with influenza-infected epithelial cells. Blood. 1988 Jul;72(1):142–149. [PubMed] [Google Scholar]
- Raymond F. L., Caton A. J., Cox N. J., Kendal A. P., Brownlee G. G. Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. Nucleic Acids Res. 1983 Oct 25;11(20):7191–7203. doi: 10.1093/nar/11.20.7191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sastry K., Zahedi K., Lelias J. M., Whitehead A. S., Ezekowitz R. A. Molecular characterization of the mouse mannose-binding proteins. The mannose-binding protein A but not C is an acute phase reactant. J Immunol. 1991 Jul 15;147(2):692–697. [PubMed] [Google Scholar]
- Schwarz R. T., Klenk H. D. Carbohydrates of influenza virus. IV. Strain-dependent variations. Virology. 1981 Sep;113(2):584–593. doi: 10.1016/0042-6822(81)90186-0. [DOI] [PubMed] [Google Scholar]
- Sumiya M., Super M., Tabona P., Levinsky R. J., Arai T., Turner M. W., Summerfield J. A. Molecular basis of opsonic defect in immunodeficient children. Lancet. 1991 Jun 29;337(8757):1569–1570. doi: 10.1016/0140-6736(91)93263-9. [DOI] [PubMed] [Google Scholar]
- Super M., Gillies S. D., Foley S., Sastry K., Schweinle J. E., Silverman V. J., Ezekowitz R. A. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet. 1992 Sep;2(1):50–55. doi: 10.1038/ng0992-50. [DOI] [PubMed] [Google Scholar]
- Super M., Levinsky R. J., Turner M. W. The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations. Clin Exp Immunol. 1990 Feb;79(2):144–150. doi: 10.1111/j.1365-2249.1990.tb05170.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thiel S., Reid K. B. Structures and functions associated with the group of mammalian lectins containing collagen-like sequences. FEBS Lett. 1989 Jun 19;250(1):78–84. doi: 10.1016/0014-5793(89)80689-1. [DOI] [PubMed] [Google Scholar]
- Wiley D. C., Skehel J. J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem. 1987;56:365–394. doi: 10.1146/annurev.bi.56.070187.002053. [DOI] [PubMed] [Google Scholar]